Although both drivers have now suffered two retirements as a result of mechanical failures this year, Hamilton has still lost substantially more points than Rosberg because of problems out of his control.
Whilst the climatic data submitted to the model is less precise, substantially more points are submitted providing more robust correlations.
This research suggests that serration does not substantially alter point performance, and this characteristic may therefore vary independently of function.
Indeed, from 2000 2007, the sustainable growth rate was substantially lower, pointing out that severe imbalances were building in the Spanish economy, not reflected on inflation.
Nevertheless, it was noteworthy that some facilities had nearly equal admission prevalences, but substantially different point prevalences (Table 2).
Even in a cohort study in Guinea-Bissau, where children were followed with weekly stool specimen examination to identify infections with enteropathogens from birth up to 2 years of age, generalized estimating equations or frailty correction to account for between-child differences did not substantially alter point estimates or precision [ 24– 26].
One of the early responders had significant variability by showing an initial response (32 point improvement) but then substantially worsening (22 points) by the end of treatment so that the patient was an eventual nonresponder.
Specifically, MEBS converges after sampling substantially fewer parameter points, because the frequency of viable points sampled by OEAMC is comparatively small, and OEAMC thus needs more sampling to estimate the viable volume to a given accuracy.
But Mr. Houchois at UBS said the difference in performance between carmakers, at least at the market-entry level, had declined substantially, to the point that other factors, like brand cachet and financing, were more the determining factors.
A median response of 1443 SFU/million PBMCs at the peak time point substantially exceeds the T-cell responses induced in any of large numbers of phase I and phase II trials of potent vectored vaccines in HIV, malaria, and cancer [ 21, 22].
